Physician profile

Edwin Acosta

General Practice (Dentist) · Clermont, FL

NPI 1578729711

$6,021.92

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,184.60
Education$463.54

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Tulsa Dental Products LLC $4,221.19 2019
Dentsply Sirona INC $1,528.90 2019-2024 Cerec
Henry Schein, INC. $159.79 2024
Straumann USA LLC $45.00 2021
Biolase, INC. $22.55 2019
Mckesson Medical-Surgical, INC. $20.00 2021
Solventum Corporation $13.59 2024 3m Relyx, 3m Scotchbond, Clarity Aligners
Glaxosmithkline, LLC. $10.90 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Edwin Acosta

$6,021.92

in general payments reported 2019-2025

Years
2019-2024
Top company
Tulsa Dental Products LLC

https://glasscript.com/doctor/863412/edwin-acosta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.